DOCS
Get informed when a big investor buys or sells
+ FollowUndervalued by 71.3% based on the discounted cash flow analysis.
| Market cap | $4.74 Billion |
|---|---|
| Enterprise Value | $4.58 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.05 |
| Beta | 1.29 |
| Outstanding Shares | 182,569,000 |
| P/E Ratio | 28.46 |
|---|---|
| PEG | -52.32 |
| Price to Sales | 8.38 |
| Price to Book Ratio | 5.03 |
| Enterprise Value to Revenue | 6.99 |
| Enterprise Value to EBIT | 22.82 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.13 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.6979▲ 68.53% |
|---|---|
| Total Calls | 976,000▲ 9.39% |
| Total Puts | 1,657,175▲ 83.42% |
Holdings and activity of institutional investors.
| Ownership % | 71.15%▲ 3.77% |
|---|---|
| Total Invested | $2.81B▼ 5.00% |
| Investors Holding | 375▼ 69.00% |
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...